Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma

C. L. Maini, A. Tofani, R. Sciuto, S. Carpano, M. Crecco, C. Manni, M. Lopez

Research output: Contribution to journalArticle

Abstract

Thallium-201 scintigraphy was used to evaluate chemotherapeutic response in a case of rhabdomyosarcoma treated with epirubicin. A scintigraphic semiquantitative index of tumor viability was correlated with MRI and clinical assessment. Both imaging studies were performed before therapy and after treatment involving a cumulative dose of 640 mg/m2 of epirubicin. A very good inverse correlation was observed between Tl-201 uptake and tumor necrosis evaluated by MRI, leading to the conclusion that sequential Tl-201 scintigraphy may have a role not only in delineating the extent of the tumor, but in objectively assessing tumor response to therapeutic interventions. The proposed scintigraphic method is much simpler to perform and less expensive than MRI-derived semiquantitative measurement of tumor necrosis.

Original languageEnglish
Pages (from-to)607-610
Number of pages4
JournalClinical Nuclear Medicine
Volume19
Issue number7
Publication statusPublished - 1994

Fingerprint

Rhabdomyosarcoma
Thallium
Radionuclide Imaging
Epirubicin
Neoplasms
Necrosis
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Maini, C. L., Tofani, A., Sciuto, R., Carpano, S., Crecco, M., Manni, C., & Lopez, M. (1994). Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma. Clinical Nuclear Medicine, 19(7), 607-610.

Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma. / Maini, C. L.; Tofani, A.; Sciuto, R.; Carpano, S.; Crecco, M.; Manni, C.; Lopez, M.

In: Clinical Nuclear Medicine, Vol. 19, No. 7, 1994, p. 607-610.

Research output: Contribution to journalArticle

Maini, CL, Tofani, A, Sciuto, R, Carpano, S, Crecco, M, Manni, C & Lopez, M 1994, 'Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma', Clinical Nuclear Medicine, vol. 19, no. 7, pp. 607-610.
Maini CL, Tofani A, Sciuto R, Carpano S, Crecco M, Manni C et al. Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma. Clinical Nuclear Medicine. 1994;19(7):607-610.
Maini, C. L. ; Tofani, A. ; Sciuto, R. ; Carpano, S. ; Crecco, M. ; Manni, C. ; Lopez, M. / Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma. In: Clinical Nuclear Medicine. 1994 ; Vol. 19, No. 7. pp. 607-610.
@article{0460483a66fe4654bb179cfbbf98f65c,
title = "Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma",
abstract = "Thallium-201 scintigraphy was used to evaluate chemotherapeutic response in a case of rhabdomyosarcoma treated with epirubicin. A scintigraphic semiquantitative index of tumor viability was correlated with MRI and clinical assessment. Both imaging studies were performed before therapy and after treatment involving a cumulative dose of 640 mg/m2 of epirubicin. A very good inverse correlation was observed between Tl-201 uptake and tumor necrosis evaluated by MRI, leading to the conclusion that sequential Tl-201 scintigraphy may have a role not only in delineating the extent of the tumor, but in objectively assessing tumor response to therapeutic interventions. The proposed scintigraphic method is much simpler to perform and less expensive than MRI-derived semiquantitative measurement of tumor necrosis.",
author = "Maini, {C. L.} and A. Tofani and R. Sciuto and S. Carpano and M. Crecco and C. Manni and M. Lopez",
year = "1994",
language = "English",
volume = "19",
pages = "607--610",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma

AU - Maini, C. L.

AU - Tofani, A.

AU - Sciuto, R.

AU - Carpano, S.

AU - Crecco, M.

AU - Manni, C.

AU - Lopez, M.

PY - 1994

Y1 - 1994

N2 - Thallium-201 scintigraphy was used to evaluate chemotherapeutic response in a case of rhabdomyosarcoma treated with epirubicin. A scintigraphic semiquantitative index of tumor viability was correlated with MRI and clinical assessment. Both imaging studies were performed before therapy and after treatment involving a cumulative dose of 640 mg/m2 of epirubicin. A very good inverse correlation was observed between Tl-201 uptake and tumor necrosis evaluated by MRI, leading to the conclusion that sequential Tl-201 scintigraphy may have a role not only in delineating the extent of the tumor, but in objectively assessing tumor response to therapeutic interventions. The proposed scintigraphic method is much simpler to perform and less expensive than MRI-derived semiquantitative measurement of tumor necrosis.

AB - Thallium-201 scintigraphy was used to evaluate chemotherapeutic response in a case of rhabdomyosarcoma treated with epirubicin. A scintigraphic semiquantitative index of tumor viability was correlated with MRI and clinical assessment. Both imaging studies were performed before therapy and after treatment involving a cumulative dose of 640 mg/m2 of epirubicin. A very good inverse correlation was observed between Tl-201 uptake and tumor necrosis evaluated by MRI, leading to the conclusion that sequential Tl-201 scintigraphy may have a role not only in delineating the extent of the tumor, but in objectively assessing tumor response to therapeutic interventions. The proposed scintigraphic method is much simpler to perform and less expensive than MRI-derived semiquantitative measurement of tumor necrosis.

UR - http://www.scopus.com/inward/record.url?scp=0028244399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028244399&partnerID=8YFLogxK

M3 - Article

C2 - 7924102

AN - SCOPUS:0028244399

VL - 19

SP - 607

EP - 610

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 7

ER -